@article{article, title  = {{Fracture-related hospitalisations in de novo advanced or metastatic hormone-sensitive prostate cancer: Secondary analysis of the STAMPEDE abiraterone acetate plus prednisone +/- enzalutamide and M1|RT phase 3 trials using health systems data}},

 publisher = {{Elsevier BV}},

 url = {{https://doi.org/10.1016/s0302-2838(24)01218-1 }},

 year = {{2024}},

 month = {{3}},

 author = {{Jones C and Dutey-Magni P and Murphy L and Murray M and Brown J and Mccloskey E and Parmar MKB and Parker C and Attard G and James ND and Sydes MR et al}},

 doi = {{10.1016/s0302-2838(24)01218-1}},

 volume = {{85}},

 journal = {{European Urology}},

 pages = {{S1583-S1583}},

 note = {{Accessed on 2025/08/08}}}